TRINESSA Trademark

Trademark Overview

On Monday, September 23, 2002, a trademark application was filed for TRINESSA with the United States Patent and Trademark Office. The USPTO has given the TRINESSA trademark a serial number of 76454127. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, February 14, 2014. This trademark is owned by Watson Pharmaceuticals, Inc.. The TRINESSA trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS, NAMELY, ORAL CONTRACEPTIVES
trinessa

General Information

Serial Number76454127
Word MarkTRINESSA
Filing DateMonday, September 23, 2002
Status800 - REGISTERED AND RENEWED
Status DateFriday, February 14, 2014
Registration Number2851647
Registration DateTuesday, June 8, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2003

Trademark Statements

Goods and ServicesPHARMACEUTICALS, NAMELY, ORAL CONTRACEPTIVES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2002
Primary Code005
First Use Anywhere DateMonday, December 29, 2003
First Use In Commerce DateMonday, December 29, 2003

Trademark Owner History

Party NameACTAVIS HOLDCO US, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameACTAVIS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameWatson Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882
Party NameWatson Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882
Party NameWatson Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882

Trademark Events

Event DateEvent Description
Thursday, June 8, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, February 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 14, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 14, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, February 14, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 30, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, February 14, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 30, 2014TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 16, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 19, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 24, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 24, 2009CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 12, 2009TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 3, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 8, 2004REGISTERED-PRINCIPAL REGISTER
Friday, March 19, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 12, 2004ASSIGNED TO EXAMINER
Thursday, March 11, 2004CASE FILE IN TICRS
Friday, March 5, 2004STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 27, 2004USE AMENDMENT FILED
Tuesday, January 27, 2004PAPER RECEIVED
Wednesday, November 12, 2003SOU EXTENSION 1 GRANTED
Thursday, October 9, 2003SOU EXTENSION 1 FILED
Thursday, October 9, 2003PAPER RECEIVED
Tuesday, June 24, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 1, 2003PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2003NOTICE OF PUBLICATION
Friday, January 31, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 31, 2003ASSIGNED TO EXAMINER

Related Keywords

trinessa contraceptives oral namely pharmaceuticals